혈액종양내과손병석

전문분야
림프종, 다발골수종, 고형암 (유방암, 비뇨생식기암, 육종, 희귀암)
진료일정 외래전문센터특수클리닉
진료일정표
날짜 9(월) 10(화) 11(수) 12(목) 13(금) 14(토)
오전
오후
외래
외래
외래
외래
외래
휴진일정
  • 2019.12.09(월) ~ 2019.12.11(수) : 국내학회
진료예약
TAG

경력

  • 경희대학교 의과대학 의학학사 (2004)
  • 울산대학교 의과대학원 의학석사 (2010)
  • 울산대학교 의과대학원 의학박사 (2012)
  • 서울 아산 병원 수련의 (2004-2005)
  • 서울 아산 병원 전공의 (2005-2009)
  • 서울 아산 병원 종양내과 전임의 (2009-2010)
  • 인제대학교 상계백병원 혈액종양내과 임상조교수 (2010-2011)
  • 인제대학교 상계백병원 혈액종양내과 조교수 (2011-2016)
  • (현) 인제대학교 상계백병원 혈액종양내과 부교수

주요활동

  • 한국임상암학회 정회원
  • 대한항암요법연구회 정회원
  • 대한조혈모세포이식학회 정회원
  • 대한혈액학회 정회원
  • 대한암학회 평생회원
  • 한국혈전지혈학회 정회원
  • 한국정맥경장영양학회 정회원
  • 미국임상종양학회 (ASCO) 정회원
  • 유럽종양학회 (ESMO) 정회원

연구업적

  • Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor, Targeted Oncology, 2015.
  • Triplet cytotoxic chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced pancreatic cancer, Oncology Letters, vol. 10, no. 2, pp. 1204-1210, 2015.
  • Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer, Oncology (Switzerland), vol. 87, no. 5, pp. 280-292, 2014.
  • The Role of Surgical Resection Following Imatinib Treatment in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses, Annals of Surgical Oncology, vol. 21, no. 13, pp. 4211-4217, 2014.
  • The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST, Annals of Surgical Oncology, vol. 20, no. 13, pp. 4212-4218, 2013.
  • The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin's lymphoma patients, Annals of Hematology, vol. 92, no. 10, pp. 1369-1377, 2013.
  • Thinprep cytological findings of desmoplastic small round cell tumor with extensive glandular differentiation: A case study, Korean Journal of Pathology, vol. 47, no. 2, pp. 182-187, 2013.
  • Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater, Tumori, vol. 99, no. 2, pp. 139-144, 2013.
  • The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma, Annals of Hematology, vol. 91, no. 11, pp. 1731-1739, 2012.
  • The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: A retrospective study, Onkologie, vol. 35, no. 7-8, pp. 432-438, 2012.
  • The role of prophylactic antimicrobials during autologous stem cell transplantation: A single-center experience, European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 7, pp. 1653-1661, 2012.
  • A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer, Tumori, vol. 97, no. 6, pp. 698-703, 2011.
  • Updated longitudinal data on acute exacerbation of chronic hepatitis b in patients with breast cancer receiving anthracyclinebased adjuvant chemotherapy: Therapeutic vs. Pre-emptive use of Lamivudine, Japanese Journal of Clinical Oncology, vol. 41, no. 9, pp. 1059-1066, 2011.
  • Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP, Annals of Hematology, vol. 90, no. 7, pp. 797-802, 2011.
  • Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: A single-center experience, Bone Marrow Transplantation, vol. 46, no. 1, pp. 105-109, 2011.
  • Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma, Korean Journal of Internal Medicine, vol. 25, no. 3, pp. 301-308, 2010.
  • The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients, Oncology, vol. 77, no. 3-4, pp. 224-230, 2009.
  • Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma, Transfusion, vol. 49, no. 9, pp. 1890-1900, 2009.
  • Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma, Bone Marrow Transplantation, vol. 44, no. 5, pp. 287-293, 2009.
  • Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: Retrospective analysis of 162 patients, Oncology, vol. 76, no. 2, pp. 126-132, 2009.
  • 이외
  • Epithelial-myoepithelial carcinoma of the nasopharynx: A case report and review of the literature, Oncology Letters, vol. 10, no. 2, pp. 927-930, 2015.
  • Angiosarcomas of the bilateral breast and heart: Which one is the primary site?, Korean Journal of Internal Medicine, vol. 27, no. 2, pp. 224-228, 2012.
  • A Case of histiocytic sarcoma presenting with primary bone marrow involvement, Journal of Korean Medical Science, vol. 25, no. 2, pp. 313-316, 2010.
  • Three cases of paragonimiasis in a family, Korean Journal of Parasitology, vol. 47, no. 3, pp. 281-285, 2009.
최고의 진료로 여러분의 건강을 지켜드립니다.